Document is current

Article History

Received: 4 December 2024

Accepted: 19 February 2025

First Online: 22 April 2025

Declarations

:

: Javier de Castro reports personal fees from AstraZeneca, Bristol Myers Squibb, Hoffmann-La Roche, Merck Sharp and Dohme, Boehringer Ingelheim, Janssen, Lilly, Sanofi, Takeda, Pfizer, Glaxo Smith Kline, and Gilead. Patricia Alonso-Fernández reports personal fees from AstraZeneca. José Javier Castrodeza reports personal fees from AstraZeneca. Ángel Gayete reports personal fees from AstraZeneca. Florentino Hernando reports personal fees from AstraZeneca and Bristol Myers Squibb. Bartomeu Massuti reports personal fees from AstraZeneca. Luis Paz-Ares reports grants from AstraZeneca, Merck Sharp and Dohme, Pfizer, and Bristol Myers Squibb, and personal fees from Lilly, Merck Sharp and Dohme, Roche, Pharmamar, Merck, AstraZeneca, Novartis, Servier, Amgen, Pfizer, Sanofi, Bayer, Bristol Myers Squibb, Mirati, Glaxo Smith Kline, Janssen, Takeda, and Daiichi Sankyo. Antoni Sisó-Almirall reports personal fees from AstraZeneca. David Vicente reports personal fees from AstraZeneca, Pfizer, Roche, Amgen, Gilead, Janssen, Daiichi Sankyo, Merck Sharp and Dohme, Bristol Myers Squibb, Merck, and Takeda. Laureano Molins reports personal fees from AstraZeneca and Ezisurg.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of the study formal consent is not required.